#healthcare #Australia #Gold Coast #ChemDAQ #Proline Medical

ChemDAQ and Proline Medical Join Forces for Safety

In an exciting development for Australian healthcare, ChemDAQ, a premier provider of hazardous gas monitoring solutions, has announced a strategic partnership with Proline Medical, a pivotal player in infection prevention and sterilization solutions within Australia. This collaboration is set to revolutionize the safety protocols in hospitals by enhancing the continuous monitoring of hazardous chemical vapors.

A New Era for Chemical Safety in Hospitals

Starting December 1, 2026, Australia will implement new Workplace Exposure Limits (WELs) aimed at significantly reducing the allowable exposure levels for hazardous substances, such as hydrogen peroxide and peracetic acid. ChemDAQ's innovative monitoring solutions for these gases will play a crucial role in helping hospitals meet these new regulations. The partnership combines ChemDAQ's high-quality monitoring technology with Proline Medical’s extensive experience in the healthcare sector to foster a safer working environment for hospital staff.

Understanding the Need for Monitoring

The healthcare environment can often expose workers to hazardous chemicals used in sterilization and disinfection. Increased focus on occupational safety and new regulations necessitate the implementation of real-time monitoring systems that provide accurate data on chemical exposure levels. ChemDAQ's technology is designed precisely for this purpose, enabling reprocessing departments to manage and mitigate risks effectively.

Statements from the Leaders

Alex Hilliker, Executive Vice President of ChemDAQ, emphasized the importance of protecting staff with the same rigor that patient safety is given. He stated, "Proline Medical has established significant trust within Australian reprocessing departments, reflecting a shared belief in prioritizing safety for both patients and staff. With the new WELs approaching, we are eager to collaborate in equipping hospitals with tools essential for real-time risk assessment and management of chemical exposure."

In parallel, Julianne Schipelliti, Director at Proline Medical, highlighted the company's commitment to ensuring the safety of reprocessing personnel. "Our partnership with ChemDAQ enhances our capability to offer proven monitoring technology to Australian healthcare facilities. By collaborating, we are raising awareness of occupational exposure risks and reinforcing workplace safety protocols."

Foundations for Future Growth

To formally introduce this partnership and its implications for the healthcare sector, Proline Medical will present their initiatives at the upcoming Federation of Sterilizing Research and Advisory Councils of Australia (FSRACA) National Conference. Scheduled from September 30 to October 2, 2026, at the Gold Coast Convention and Exhibition Centre, this event will allow the healthcare community to gain insights into the latest advancements in chemical vapor monitoring. Attendees can discuss specific concerns regarding chemical safety with Proline Medical representatives at Booth 9.

About ChemDAQ and Proline Medical

ChemDAQ is recognized for its comprehensive monitoring solutions catering to various industries, including healthcare, medical device manufacturing, and food processing. Their commitment to fostering safer work environments makes them a key player in health and safety technologies. More about their solutions can be found at www.chemdaq.com.

Proline Medical is an Australian healthcare company devoted to providing innovative sterilization and infection control solutions. Their focus on compliance and education empowers healthcare facilities across the nation. To learn more, visit www.prolinemedical.com.au.

Conclusion

As ChemDAQ and Proline Medical unite their strengths, Australian hospitals can look forward to enhanced safety measures that will protect both staff and patients alike. This partnership signifies a commitment to fostering a culture of safety that can greatly benefit the healthcare sector in the country.